Intrinsiqq

Target Healthcare REIT plc (THRL.XLON) Quality Score

THRL.XLON
Quality69

Growth remains strong (avg 100/100), but business quality is pulling the composite down (avg 50/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

P/FFO Multiple
100/100
8.1x

8.1x OCF, reasonable REIT valuation

Cash Flow Multiple
90/100
16.8x

Under 20x cash flow, well covered

Revenue Growth
100/100
15.7%

Above 7% CAGR, strong REIT expansion

FFO Growth
100/100
23.3%

Above 7% FFO CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
0/100
30.5%

Heavy dilution above 5%

Dividend Coverage
100/100
41%

41% payout of FFO, well covered

Target Healthcare REIT (THRL.XLON) quality: score, margins and returns

Target Healthcare REIT (THRL.XLON) scores 69/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 6 metrics each scored 0 to 100. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Target Healthcare REIT (THRL.XLON) a high-quality business?+

Target Healthcare REIT scores 69 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a solid business on these measures. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Target Healthcare REIT's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from THRL.XLON's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Target Healthcare REIT scores well and where it falls behind.

How profitable is Target Healthcare REIT?+

Target Healthcare REIT runs a net margin of about 93.0%. Revenue has grown at roughly 27.5% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

More on THRL.XLON: Overview · DCF valuation · Dividend safety · Financials
How the market compares: US profitability statistics

Related stocks: REIT - Healthcare Facilities

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing THRL.XLON

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.